175 related articles for article (PubMed ID: 10395071)
21. Diminished levels of protein kinase A RI alpha and RI beta transcripts and proteins in systemic lupus erythematosus T lymphocytes.
Laxminarayana D; Khan IU; Mishra N; Olorenshaw I; Taskén K; Kammer GM
J Immunol; 1999 May; 162(9):5639-48. PubMed ID: 10228048
[TBL] [Abstract][Full Text] [Related]
22. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K
J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of protein kinase A (PKA) regulatory subunit RIα by protein kinase G (PKG) primes PKA for catalytic activity in cells.
Haushalter KJ; Casteel DE; Raffeiner A; Stefan E; Patel HH; Taylor SS
J Biol Chem; 2018 Mar; 293(12):4411-4421. PubMed ID: 29378851
[TBL] [Abstract][Full Text] [Related]
24. Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.
Cho-Chung YS; Nesterova M; Pepe S; Lee GR; Noguchi K; Srivastava RK; Srivastava AR; Alper O; Park YG; Lee YN
Front Biosci; 1999 Dec; 4():D898-907. PubMed ID: 10577386
[TBL] [Abstract][Full Text] [Related]
25. Growth-regulatory effect of gastrin on human colon cancer cell lines is determined by protein kinase a isoform content.
Bold RJ; Alpard S; Ishizuka J; Townsend CM; Thompson JC
Regul Pept; 1994 Aug; 53(1):61-70. PubMed ID: 7800859
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A.
Farrow B; Rychahou P; Murillo C; O'connor KL; Iwamura T; Evers BM
Surgery; 2003 Aug; 134(2):197-205. PubMed ID: 12947318
[TBL] [Abstract][Full Text] [Related]
27. Characterization of PKA isoforms and kinase-dependent activation of chloride secretion in T84 cells.
Singh AK; Taskén K; Walker W; Frizzell RA; Watkins SC; Bridges RJ; Bradbury NA
Am J Physiol; 1998 Aug; 275(2):C562-70. PubMed ID: 9688611
[TBL] [Abstract][Full Text] [Related]
28. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.
Cho-Chung YS; Clair T
Pharmacol Ther; 1993 Nov; 60(2):265-88. PubMed ID: 8022860
[TBL] [Abstract][Full Text] [Related]
29. Patterns of cyclic AMP-dependent protein kinase gene expression during ontogeny of the murine palate.
Greene RM; Lloyd MR; Uberti M; Nugent P; Pisano MM
J Cell Physiol; 1995 Jun; 163(3):431-40. PubMed ID: 7775586
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion.
Neary CL; Nesterova M; Cho YS; Cheadle C; Becker KG; Cho-Chung YS
Oncogene; 2004 Nov; 23(54):8847-56. PubMed ID: 15480415
[TBL] [Abstract][Full Text] [Related]
31. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
[TBL] [Abstract][Full Text] [Related]
32. Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.
Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung YS; Clair T; Skalhegg BS; Bianco AR
Cytometry; 1994 Jan; 15(1):73-9. PubMed ID: 8162827
[TBL] [Abstract][Full Text] [Related]
33. Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278).
Yang WL; Ravatn R; Kudoh K; Alabanza L; Chin KV
Biochem Biophys Res Commun; 2010 Jan; 391(3):1318-23. PubMed ID: 20026299
[TBL] [Abstract][Full Text] [Related]
34. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
35. Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP-dependent protein kinase.
Barradeau S; Imaizumi-Scherrer T; Weiss MC; Faust DM
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5037-42. PubMed ID: 11296260
[TBL] [Abstract][Full Text] [Related]
36. Contribution of the carboxyl-terminal regional of the cAMP-dependent protein kinase type I alpha regulatory subunit to cyclic nucleotide interactions.
Kapphahn MA; Shabb JB
Arch Biochem Biophys; 1997 Dec; 348(2):347-56. PubMed ID: 9434747
[TBL] [Abstract][Full Text] [Related]
37. Cyclic-AMP and pseudosubstrate effects on type-I A-kinase regulatory and catalytic subunit binding kinetics.
Anand G; Taylor SS; Johnson DA
Biochemistry; 2007 Aug; 46(32):9283-91. PubMed ID: 17658893
[TBL] [Abstract][Full Text] [Related]
38. Experimental gene therapy of human colon cancer.
Bold RJ; Warren RE; Ishizuka J; Cho-Chung YS; Townsend CM; Thompson JC
Surgery; 1994 Aug; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
[TBL] [Abstract][Full Text] [Related]
39. RIalpha influences cellular proliferation in cancer cells by transporting RFC40 into the nucleus.
Gupte RS; Pozarowski P; Grabarek J; Traganos F; Darzynkiewicz Z; Lee MY
Cancer Biol Ther; 2005 Apr; 4(4):429-37. PubMed ID: 15846072
[TBL] [Abstract][Full Text] [Related]
40. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
Neary CL; Cho-Chung YS
Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
